BNP/CALL/FRESENIUS/38/0.1/18.12.26 Share Price

Warrant

DE000PC3ZYW3

Real-time Boerse Frankfurt Warrants 07:50:56 13/06/2024 pm IST
0.31 EUR 0.00% Intraday chart for BNP/CALL/FRESENIUS/38/0.1/18.12.26
1 month+14.81%
3 months+63.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
13/24/13 0.31 0.00%
12/24/12 0.31 +3.33%
11/24/11 0.3 -9.09%
10/24/10 0.33 0.00%
07/24/07 0.33 0.00%

Real-time Boerse Frankfurt Warrants

Last update June 13, 2024 at 07:50 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC3ZYW
ISINDE000PC3ZYW3
Date issued 26/01/2024
Strike 38
Maturity 18/12/2026 (918 Days)
Parity 10 : 1
Emission price 0.17
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.34
Lowest since issue 0.13
Delta0.44x
Omega 3.934
Premium37.51x
Gearing8.98x
Moneyness 0.7913
Difference Strike 8.245
Difference Strike %+21.70%
Spread 0.03
Spread %8.57%
Theoretical value 0.3350
Implied Volatility 27.68 %
Total Loss Probability 72.54 %
Intrinsic value 0.000000
Present value 0.3350
Break even 41.35 €
Theta-0x
Vega0.02x
Rho0.02x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
30.05 EUR
Average target price
37.26 EUR
Spread / Average Target
+23.98%
Consensus